nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP3A7—Irinotecan—colon cancer	0.0683	0.16	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0683	0.16	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0597	0.14	CbGbCtD
Ziprasidone—CYP3A7—Vincristine—colon cancer	0.0597	0.14	CbGbCtD
Ziprasidone—CYP3A5—Irinotecan—colon cancer	0.0512	0.12	CbGbCtD
Ziprasidone—CYP3A5—Vincristine—colon cancer	0.0448	0.105	CbGbCtD
Ziprasidone—CYP1A2—Fluorouracil—colon cancer	0.0366	0.0859	CbGbCtD
Ziprasidone—HTR3A—myenteric nerve plexus—colon cancer	0.0222	0.123	CbGeAlD
Ziprasidone—CYP3A4—Irinotecan—colon cancer	0.02	0.0469	CbGbCtD
Ziprasidone—CHRM3—ureter—colon cancer	0.0176	0.0968	CbGeAlD
Ziprasidone—CYP3A4—Vincristine—colon cancer	0.0175	0.041	CbGbCtD
Ziprasidone—HTR7—myenteric nerve plexus—colon cancer	0.0144	0.0793	CbGeAlD
Ziprasidone—CHRM3—muscle of abdomen—colon cancer	0.0126	0.0697	CbGeAlD
Ziprasidone—HTR7—vein—colon cancer	0.00928	0.0511	CbGeAlD
Ziprasidone—HTR2A—myenteric nerve plexus—colon cancer	0.00898	0.0495	CbGeAlD
Ziprasidone—HTR2A—vein—colon cancer	0.00578	0.0319	CbGeAlD
Ziprasidone—HTR1B—blood vessel—colon cancer	0.00382	0.021	CbGeAlD
Ziprasidone—HTR1D—blood vessel—colon cancer	0.00369	0.0204	CbGeAlD
Ziprasidone—HTR7—endothelium—colon cancer	0.00319	0.0176	CbGeAlD
Ziprasidone—HTR7—blood vessel—colon cancer	0.00294	0.0162	CbGeAlD
Ziprasidone—H1F0—embryo—colon cancer	0.00285	0.0157	CbGeAlD
Ziprasidone—CHRM5—epithelium—colon cancer	0.00269	0.0148	CbGeAlD
Ziprasidone—DRD5—lymphoid tissue—colon cancer	0.00231	0.0127	CbGeAlD
Ziprasidone—ADRA1B—renal system—colon cancer	0.00228	0.0126	CbGeAlD
Ziprasidone—H1F0—smooth muscle tissue—colon cancer	0.00224	0.0123	CbGeAlD
Ziprasidone—H1F0—renal system—colon cancer	0.00215	0.0119	CbGeAlD
Ziprasidone—HTR2A—endothelium—colon cancer	0.00199	0.011	CbGeAlD
Ziprasidone—HTR2A—blood vessel—colon cancer	0.00184	0.0101	CbGeAlD
Ziprasidone—H1F0—lymphoid tissue—colon cancer	0.00179	0.00986	CbGeAlD
Ziprasidone—CYP3A7—liver—colon cancer	0.00177	0.00978	CbGeAlD
Ziprasidone—H1F0—digestive system—colon cancer	0.00177	0.00974	CbGeAlD
Ziprasidone—HTR3A—digestive system—colon cancer	0.00168	0.00929	CbGeAlD
Ziprasidone—H1F0—bone marrow—colon cancer	0.00163	0.00897	CbGeAlD
Ziprasidone—H1F0—vagina—colon cancer	0.00156	0.0086	CbGeAlD
Ziprasidone—CYP3A7-CYP3A51P—liver—colon cancer	0.00151	0.00832	CbGeAlD
Ziprasidone—CHRM3—smooth muscle tissue—colon cancer	0.00145	0.00799	CbGeAlD
Ziprasidone—HTR7—epithelium—colon cancer	0.00143	0.0079	CbGeAlD
Ziprasidone—CHRM3—renal system—colon cancer	0.0014	0.0077	CbGeAlD
Ziprasidone—HTR1A—renal system—colon cancer	0.00139	0.00766	CbGeAlD
Ziprasidone—ADRA1A—epithelium—colon cancer	0.00138	0.00762	CbGeAlD
Ziprasidone—HTR7—smooth muscle tissue—colon cancer	0.00138	0.00761	CbGeAlD
Ziprasidone—HTR7—renal system—colon cancer	0.00133	0.00732	CbGeAlD
Ziprasidone—H1F0—liver—colon cancer	0.00132	0.00725	CbGeAlD
Ziprasidone—SLC6A4—digestive system—colon cancer	0.00128	0.00708	CbGeAlD
Ziprasidone—ADRA1A—renal system—colon cancer	0.00128	0.00707	CbGeAlD
Ziprasidone—KCNH2—renal system—colon cancer	0.00124	0.00682	CbGeAlD
Ziprasidone—ADRA2C—renal system—colon cancer	0.00122	0.00673	CbGeAlD
Ziprasidone—CHRM3—digestive system—colon cancer	0.00115	0.00631	CbGeAlD
Ziprasidone—HTR2A—embryo—colon cancer	0.00109	0.00603	CbGeAlD
Ziprasidone—HTR7—digestive system—colon cancer	0.00109	0.00601	CbGeAlD
Ziprasidone—HRH1—epithelium—colon cancer	0.00107	0.0059	CbGeAlD
Ziprasidone—ADRA1A—lymphoid tissue—colon cancer	0.00106	0.00587	CbGeAlD
Ziprasidone—CYP1A2—renal system—colon cancer	0.00106	0.00584	CbGeAlD
Ziprasidone—HRH1—smooth muscle tissue—colon cancer	0.00103	0.00568	CbGeAlD
Ziprasidone—CYP3A5—renal system—colon cancer	0.00102	0.00563	CbGeAlD
Ziprasidone—H1F0—lymph node—colon cancer	0.00101	0.00556	CbGeAlD
Ziprasidone—KCNH2—bone marrow—colon cancer	0.000936	0.00516	CbGeAlD
Ziprasidone—KCNH2—vagina—colon cancer	0.000897	0.00494	CbGeAlD
Ziprasidone—HTR2A—epithelium—colon cancer	0.000893	0.00492	CbGeAlD
Ziprasidone—ADRA2C—vagina—colon cancer	0.000885	0.00488	CbGeAlD
Ziprasidone—CYP1A2—digestive system—colon cancer	0.000869	0.00479	CbGeAlD
Ziprasidone—HTR2A—smooth muscle tissue—colon cancer	0.000861	0.00474	CbGeAlD
Ziprasidone—CYP3A5—digestive system—colon cancer	0.000838	0.00462	CbGeAlD
Ziprasidone—HTR2A—renal system—colon cancer	0.000829	0.00457	CbGeAlD
Ziprasidone—HRH1—digestive system—colon cancer	0.000814	0.00449	CbGeAlD
Ziprasidone—HTR7—liver—colon cancer	0.000812	0.00448	CbGeAlD
Ziprasidone—ADRA1A—liver—colon cancer	0.000783	0.00432	CbGeAlD
Ziprasidone—CYP3A4—renal system—colon cancer	0.000767	0.00423	CbGeAlD
Ziprasidone—CYP2D6—renal system—colon cancer	0.000755	0.00416	CbGeAlD
Ziprasidone—ADRA2C—liver—colon cancer	0.000746	0.00411	CbGeAlD
Ziprasidone—CYP3A5—vagina—colon cancer	0.00074	0.00408	CbGeAlD
Ziprasidone—HRH1—vagina—colon cancer	0.000719	0.00396	CbGeAlD
Ziprasidone—ADRA2A—vagina—colon cancer	0.000706	0.00389	CbGeAlD
Ziprasidone—HTR2A—digestive system—colon cancer	0.00068	0.00375	CbGeAlD
Ziprasidone—CYP1A2—liver—colon cancer	0.000648	0.00357	CbGeAlD
Ziprasidone—CYP3A4—digestive system—colon cancer	0.000629	0.00347	CbGeAlD
Ziprasidone—CYP3A5—liver—colon cancer	0.000625	0.00344	CbGeAlD
Ziprasidone—CYP2D6—digestive system—colon cancer	0.000619	0.00341	CbGeAlD
Ziprasidone—HTR2A—vagina—colon cancer	0.0006	0.00331	CbGeAlD
Ziprasidone—KCNH2—lymph node—colon cancer	0.00058	0.0032	CbGeAlD
Ziprasidone—ADRA2C—lymph node—colon cancer	0.000572	0.00315	CbGeAlD
Ziprasidone—Hyperglycaemia—Capecitabine—colon cancer	0.000513	0.00136	CcSEcCtD
Ziprasidone—Hypertension—Irinotecan—colon cancer	0.000511	0.00136	CcSEcCtD
Ziprasidone—Pneumonia—Capecitabine—colon cancer	0.00051	0.00136	CcSEcCtD
Ziprasidone—Leukopenia—Fluorouracil—colon cancer	0.000508	0.00135	CcSEcCtD
Ziprasidone—Infestation NOS—Capecitabine—colon cancer	0.000507	0.00135	CcSEcCtD
Ziprasidone—Infestation—Capecitabine—colon cancer	0.000507	0.00135	CcSEcCtD
Ziprasidone—HTR2A—liver—colon cancer	0.000506	0.00279	CbGeAlD
Ziprasidone—Lethargy—Methotrexate—colon cancer	0.0005	0.00133	CcSEcCtD
Ziprasidone—Cerebrovascular accident—Methotrexate—colon cancer	0.0005	0.00133	CcSEcCtD
Ziprasidone—Renal failure—Capecitabine—colon cancer	0.000498	0.00133	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Capecitabine—colon cancer	0.000497	0.00132	CcSEcCtD
Ziprasidone—Jaundice—Capecitabine—colon cancer	0.000494	0.00132	CcSEcCtD
Ziprasidone—Infection—Vincristine—colon cancer	0.000493	0.00131	CcSEcCtD
Ziprasidone—Conjunctivitis—Capecitabine—colon cancer	0.000493	0.00131	CcSEcCtD
Ziprasidone—Osteoarthritis—Methotrexate—colon cancer	0.00049	0.0013	CcSEcCtD
Ziprasidone—Confusional state—Irinotecan—colon cancer	0.000487	0.0013	CcSEcCtD
Ziprasidone—Nervous system disorder—Vincristine—colon cancer	0.000487	0.00129	CcSEcCtD
Ziprasidone—Thrombocytopenia—Vincristine—colon cancer	0.000486	0.00129	CcSEcCtD
Ziprasidone—Haematuria—Capecitabine—colon cancer	0.000483	0.00129	CcSEcCtD
Ziprasidone—Aripiprazole—ABCB1—colon cancer	0.000483	0.395	CrCbGaD
Ziprasidone—Chest pain—Fluorouracil—colon cancer	0.000483	0.00128	CcSEcCtD
Ziprasidone—Myalgia—Fluorouracil—colon cancer	0.000483	0.00128	CcSEcCtD
Ziprasidone—Trazodone—ABCB1—colon cancer	0.000481	0.393	CrCbGaD
Ziprasidone—Infection—Irinotecan—colon cancer	0.00048	0.00128	CcSEcCtD
Ziprasidone—Hyperhidrosis—Vincristine—colon cancer	0.00048	0.00128	CcSEcCtD
Ziprasidone—Epistaxis—Capecitabine—colon cancer	0.000478	0.00127	CcSEcCtD
Ziprasidone—Shock—Irinotecan—colon cancer	0.000475	0.00126	CcSEcCtD
Ziprasidone—Nervous system disorder—Irinotecan—colon cancer	0.000474	0.00126	CcSEcCtD
Ziprasidone—Thrombocytopenia—Irinotecan—colon cancer	0.000473	0.00126	CcSEcCtD
Ziprasidone—Anorexia—Vincristine—colon cancer	0.000473	0.00126	CcSEcCtD
Ziprasidone—CYP3A4—liver—colon cancer	0.000469	0.00258	CbGeAlD
Ziprasidone—Hyperhidrosis—Irinotecan—colon cancer	0.000467	0.00124	CcSEcCtD
Ziprasidone—Confusional state—Fluorouracil—colon cancer	0.000467	0.00124	CcSEcCtD
Ziprasidone—HRH1—lymph node—colon cancer	0.000465	0.00256	CbGeAlD
Ziprasidone—Hypotension—Vincristine—colon cancer	0.000464	0.00123	CcSEcCtD
Ziprasidone—Bradycardia—Capecitabine—colon cancer	0.000463	0.00123	CcSEcCtD
Ziprasidone—CYP2D6—liver—colon cancer	0.000461	0.00254	CbGeAlD
Ziprasidone—Anorexia—Irinotecan—colon cancer	0.000461	0.00123	CcSEcCtD
Ziprasidone—Ataxia—Methotrexate—colon cancer	0.000461	0.00123	CcSEcCtD
Ziprasidone—Infection—Fluorouracil—colon cancer	0.00046	0.00122	CcSEcCtD
Ziprasidone—Haemoglobin—Capecitabine—colon cancer	0.000458	0.00122	CcSEcCtD
Ziprasidone—ADRA2A—lymph node—colon cancer	0.000457	0.00252	CbGeAlD
Ziprasidone—Rhinitis—Capecitabine—colon cancer	0.000456	0.00121	CcSEcCtD
Ziprasidone—Haemorrhage—Capecitabine—colon cancer	0.000455	0.00121	CcSEcCtD
Ziprasidone—Hepatitis—Capecitabine—colon cancer	0.000455	0.00121	CcSEcCtD
Ziprasidone—Nervous system disorder—Fluorouracil—colon cancer	0.000454	0.00121	CcSEcCtD
Ziprasidone—Thrombocytopenia—Fluorouracil—colon cancer	0.000453	0.00121	CcSEcCtD
Ziprasidone—Hypoaesthesia—Capecitabine—colon cancer	0.000453	0.00121	CcSEcCtD
Ziprasidone—Liver function test abnormal—Methotrexate—colon cancer	0.000452	0.0012	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000452	0.0012	CcSEcCtD
Ziprasidone—Pharyngitis—Capecitabine—colon cancer	0.000452	0.0012	CcSEcCtD
Ziprasidone—Tachycardia—Fluorouracil—colon cancer	0.000452	0.0012	CcSEcCtD
Ziprasidone—Hypotension—Irinotecan—colon cancer	0.000452	0.0012	CcSEcCtD
Ziprasidone—Urinary tract disorder—Capecitabine—colon cancer	0.00045	0.0012	CcSEcCtD
Ziprasidone—Insomnia—Vincristine—colon cancer	0.000449	0.00119	CcSEcCtD
Ziprasidone—Oedema peripheral—Capecitabine—colon cancer	0.000448	0.00119	CcSEcCtD
Ziprasidone—Connective tissue disorder—Capecitabine—colon cancer	0.000447	0.00119	CcSEcCtD
Ziprasidone—Urethral disorder—Capecitabine—colon cancer	0.000446	0.00119	CcSEcCtD
Ziprasidone—Paraesthesia—Vincristine—colon cancer	0.000446	0.00119	CcSEcCtD
Ziprasidone—Breast disorder—Methotrexate—colon cancer	0.000443	0.00118	CcSEcCtD
Ziprasidone—Anorexia—Fluorouracil—colon cancer	0.000441	0.00117	CcSEcCtD
Ziprasidone—Visual impairment—Capecitabine—colon cancer	0.000439	0.00117	CcSEcCtD
Ziprasidone—Insomnia—Irinotecan—colon cancer	0.000437	0.00116	CcSEcCtD
Ziprasidone—Paraesthesia—Irinotecan—colon cancer	0.000434	0.00115	CcSEcCtD
Ziprasidone—Hypotension—Fluorouracil—colon cancer	0.000432	0.00115	CcSEcCtD
Ziprasidone—Decreased appetite—Vincristine—colon cancer	0.000431	0.00115	CcSEcCtD
Ziprasidone—Dyspnoea—Irinotecan—colon cancer	0.000431	0.00115	CcSEcCtD
Ziprasidone—Somnolence—Irinotecan—colon cancer	0.00043	0.00114	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Vincristine—colon cancer	0.000428	0.00114	CcSEcCtD
Ziprasidone—Fatigue—Vincristine—colon cancer	0.000428	0.00114	CcSEcCtD
Ziprasidone—Eye disorder—Capecitabine—colon cancer	0.000425	0.00113	CcSEcCtD
Ziprasidone—Dyspepsia—Irinotecan—colon cancer	0.000425	0.00113	CcSEcCtD
Ziprasidone—Tinnitus—Capecitabine—colon cancer	0.000424	0.00113	CcSEcCtD
Ziprasidone—Constipation—Vincristine—colon cancer	0.000424	0.00113	CcSEcCtD
Ziprasidone—Cardiac disorder—Capecitabine—colon cancer	0.000422	0.00112	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000422	0.00112	CcSEcCtD
Ziprasidone—Decreased appetite—Irinotecan—colon cancer	0.00042	0.00112	CcSEcCtD
Ziprasidone—Eosinophilia—Methotrexate—colon cancer	0.000419	0.00112	CcSEcCtD
Ziprasidone—Insomnia—Fluorouracil—colon cancer	0.000419	0.00111	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000417	0.00111	CcSEcCtD
Ziprasidone—Fatigue—Irinotecan—colon cancer	0.000417	0.00111	CcSEcCtD
Ziprasidone—Paraesthesia—Fluorouracil—colon cancer	0.000416	0.00111	CcSEcCtD
Ziprasidone—Constipation—Irinotecan—colon cancer	0.000413	0.0011	CcSEcCtD
Ziprasidone—Angiopathy—Capecitabine—colon cancer	0.000413	0.0011	CcSEcCtD
Ziprasidone—Dyspnoea—Fluorouracil—colon cancer	0.000413	0.0011	CcSEcCtD
Ziprasidone—Somnolence—Fluorouracil—colon cancer	0.000411	0.00109	CcSEcCtD
Ziprasidone—Immune system disorder—Capecitabine—colon cancer	0.000411	0.00109	CcSEcCtD
Ziprasidone—Mediastinal disorder—Capecitabine—colon cancer	0.00041	0.00109	CcSEcCtD
Ziprasidone—Chills—Capecitabine—colon cancer	0.000408	0.00109	CcSEcCtD
Ziprasidone—Dyspepsia—Fluorouracil—colon cancer	0.000407	0.00108	CcSEcCtD
Ziprasidone—Arrhythmia—Capecitabine—colon cancer	0.000407	0.00108	CcSEcCtD
Ziprasidone—Abdominal discomfort—Methotrexate—colon cancer	0.000406	0.00108	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Vincristine—colon cancer	0.000406	0.00108	CcSEcCtD
Ziprasidone—Decreased appetite—Fluorouracil—colon cancer	0.000402	0.00107	CcSEcCtD
Ziprasidone—Alopecia—Capecitabine—colon cancer	0.000402	0.00107	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.0004	0.00106	CcSEcCtD
Ziprasidone—Mental disorder—Capecitabine—colon cancer	0.000399	0.00106	CcSEcCtD
Ziprasidone—Feeling abnormal—Irinotecan—colon cancer	0.000398	0.00106	CcSEcCtD
Ziprasidone—Malnutrition—Capecitabine—colon cancer	0.000396	0.00105	CcSEcCtD
Ziprasidone—Erythema—Capecitabine—colon cancer	0.000396	0.00105	CcSEcCtD
Ziprasidone—Dysuria—Methotrexate—colon cancer	0.000396	0.00105	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Irinotecan—colon cancer	0.000395	0.00105	CcSEcCtD
Ziprasidone—Upper respiratory tract infection—Methotrexate—colon cancer	0.000393	0.00105	CcSEcCtD
Ziprasidone—Body temperature increased—Vincristine—colon cancer	0.000392	0.00104	CcSEcCtD
Ziprasidone—Abdominal pain—Vincristine—colon cancer	0.000392	0.00104	CcSEcCtD
Ziprasidone—Flatulence—Capecitabine—colon cancer	0.00039	0.00104	CcSEcCtD
Ziprasidone—Erectile dysfunction—Methotrexate—colon cancer	0.00039	0.00104	CcSEcCtD
Ziprasidone—Photosensitivity reaction—Methotrexate—colon cancer	0.000386	0.00103	CcSEcCtD
Ziprasidone—Back pain—Capecitabine—colon cancer	0.000383	0.00102	CcSEcCtD
Ziprasidone—Body temperature increased—Irinotecan—colon cancer	0.000382	0.00102	CcSEcCtD
Ziprasidone—Abdominal pain—Irinotecan—colon cancer	0.000382	0.00102	CcSEcCtD
Ziprasidone—Feeling abnormal—Fluorouracil—colon cancer	0.000381	0.00101	CcSEcCtD
Ziprasidone—Muscle spasms—Capecitabine—colon cancer	0.000381	0.00101	CcSEcCtD
Ziprasidone—Pneumonia—Methotrexate—colon cancer	0.00038	0.00101	CcSEcCtD
Ziprasidone—Infestation NOS—Methotrexate—colon cancer	0.000377	0.001	CcSEcCtD
Ziprasidone—Infestation—Methotrexate—colon cancer	0.000377	0.001	CcSEcCtD
Ziprasidone—Vision blurred—Capecitabine—colon cancer	0.000373	0.000994	CcSEcCtD
Ziprasidone—Tremor—Capecitabine—colon cancer	0.000371	0.000988	CcSEcCtD
Ziprasidone—Renal failure—Methotrexate—colon cancer	0.000371	0.000987	CcSEcCtD
Ziprasidone—Urticaria—Fluorouracil—colon cancer	0.000368	0.000978	CcSEcCtD
Ziprasidone—Conjunctivitis—Methotrexate—colon cancer	0.000367	0.000976	CcSEcCtD
Ziprasidone—Anaemia—Capecitabine—colon cancer	0.000366	0.000975	CcSEcCtD
Ziprasidone—Body temperature increased—Fluorouracil—colon cancer	0.000366	0.000973	CcSEcCtD
Ziprasidone—Hypersensitivity—Vincristine—colon cancer	0.000366	0.000973	CcSEcCtD
Ziprasidone—Sweating—Methotrexate—colon cancer	0.000362	0.000963	CcSEcCtD
Ziprasidone—Haematuria—Methotrexate—colon cancer	0.00036	0.000958	CcSEcCtD
Ziprasidone—Epistaxis—Methotrexate—colon cancer	0.000356	0.000947	CcSEcCtD
Ziprasidone—Vertigo—Capecitabine—colon cancer	0.000356	0.000947	CcSEcCtD
Ziprasidone—Hypersensitivity—Irinotecan—colon cancer	0.000356	0.000947	CcSEcCtD
Ziprasidone—Asthenia—Vincristine—colon cancer	0.000356	0.000947	CcSEcCtD
Ziprasidone—Syncope—Capecitabine—colon cancer	0.000355	0.000946	CcSEcCtD
Ziprasidone—Leukopenia—Capecitabine—colon cancer	0.000355	0.000944	CcSEcCtD
Ziprasidone—Palpitations—Capecitabine—colon cancer	0.00035	0.000932	CcSEcCtD
Ziprasidone—Loss of consciousness—Capecitabine—colon cancer	0.000348	0.000927	CcSEcCtD
Ziprasidone—Asthenia—Irinotecan—colon cancer	0.000347	0.000922	CcSEcCtD
Ziprasidone—Cough—Capecitabine—colon cancer	0.000346	0.00092	CcSEcCtD
Ziprasidone—Hypertension—Capecitabine—colon cancer	0.000342	0.00091	CcSEcCtD
Ziprasidone—Hypersensitivity—Fluorouracil—colon cancer	0.000341	0.000907	CcSEcCtD
Ziprasidone—Haemoglobin—Methotrexate—colon cancer	0.000341	0.000906	CcSEcCtD
Ziprasidone—Diarrhoea—Vincristine—colon cancer	0.000339	0.000903	CcSEcCtD
Ziprasidone—Haemorrhage—Methotrexate—colon cancer	0.000339	0.000902	CcSEcCtD
Ziprasidone—Hepatitis—Methotrexate—colon cancer	0.000339	0.000902	CcSEcCtD
Ziprasidone—Arthralgia—Capecitabine—colon cancer	0.000337	0.000898	CcSEcCtD
Ziprasidone—Chest pain—Capecitabine—colon cancer	0.000337	0.000898	CcSEcCtD
Ziprasidone—Myalgia—Capecitabine—colon cancer	0.000337	0.000898	CcSEcCtD
Ziprasidone—Pharyngitis—Methotrexate—colon cancer	0.000336	0.000895	CcSEcCtD
Ziprasidone—Anxiety—Capecitabine—colon cancer	0.000336	0.000895	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000335	0.000891	CcSEcCtD
Ziprasidone—Urinary tract disorder—Methotrexate—colon cancer	0.000335	0.00089	CcSEcCtD
Ziprasidone—Urethral disorder—Methotrexate—colon cancer	0.000332	0.000884	CcSEcCtD
Ziprasidone—Diarrhoea—Irinotecan—colon cancer	0.000331	0.00088	CcSEcCtD
Ziprasidone—Dry mouth—Capecitabine—colon cancer	0.00033	0.000878	CcSEcCtD
Ziprasidone—Dizziness—Vincristine—colon cancer	0.000328	0.000873	CcSEcCtD
Ziprasidone—Visual impairment—Methotrexate—colon cancer	0.000327	0.000869	CcSEcCtD
Ziprasidone—Confusional state—Capecitabine—colon cancer	0.000326	0.000868	CcSEcCtD
Ziprasidone—Infection—Capecitabine—colon cancer	0.000321	0.000855	CcSEcCtD
Ziprasidone—Dizziness—Irinotecan—colon cancer	0.00032	0.00085	CcSEcCtD
Ziprasidone—Shock—Capecitabine—colon cancer	0.000318	0.000847	CcSEcCtD
Ziprasidone—Nervous system disorder—Capecitabine—colon cancer	0.000317	0.000844	CcSEcCtD
Ziprasidone—Eye disorder—Methotrexate—colon cancer	0.000317	0.000843	CcSEcCtD
Ziprasidone—Diarrhoea—Fluorouracil—colon cancer	0.000317	0.000843	CcSEcCtD
Ziprasidone—Thrombocytopenia—Capecitabine—colon cancer	0.000317	0.000843	CcSEcCtD
Ziprasidone—Tinnitus—Methotrexate—colon cancer	0.000316	0.000841	CcSEcCtD
Ziprasidone—Tachycardia—Capecitabine—colon cancer	0.000316	0.00084	CcSEcCtD
Ziprasidone—Vomiting—Vincristine—colon cancer	0.000315	0.000839	CcSEcCtD
Ziprasidone—Cardiac disorder—Methotrexate—colon cancer	0.000314	0.000837	CcSEcCtD
Ziprasidone—Skin disorder—Capecitabine—colon cancer	0.000314	0.000836	CcSEcCtD
Ziprasidone—Rash—Vincristine—colon cancer	0.000313	0.000832	CcSEcCtD
Ziprasidone—Hyperhidrosis—Capecitabine—colon cancer	0.000313	0.000832	CcSEcCtD
Ziprasidone—Dermatitis—Vincristine—colon cancer	0.000313	0.000832	CcSEcCtD
Ziprasidone—Headache—Vincristine—colon cancer	0.000311	0.000827	CcSEcCtD
Ziprasidone—Anorexia—Capecitabine—colon cancer	0.000308	0.00082	CcSEcCtD
Ziprasidone—Angiopathy—Methotrexate—colon cancer	0.000307	0.000818	CcSEcCtD
Ziprasidone—Vomiting—Irinotecan—colon cancer	0.000307	0.000817	CcSEcCtD
Ziprasidone—Immune system disorder—Methotrexate—colon cancer	0.000306	0.000814	CcSEcCtD
Ziprasidone—Dizziness—Fluorouracil—colon cancer	0.000306	0.000814	CcSEcCtD
Ziprasidone—Mediastinal disorder—Methotrexate—colon cancer	0.000305	0.000813	CcSEcCtD
Ziprasidone—Rash—Irinotecan—colon cancer	0.000305	0.000811	CcSEcCtD
Ziprasidone—Dermatitis—Irinotecan—colon cancer	0.000304	0.00081	CcSEcCtD
Ziprasidone—Chills—Methotrexate—colon cancer	0.000304	0.000809	CcSEcCtD
Ziprasidone—Headache—Irinotecan—colon cancer	0.000303	0.000805	CcSEcCtD
Ziprasidone—Hypotension—Capecitabine—colon cancer	0.000302	0.000804	CcSEcCtD
Ziprasidone—Alopecia—Methotrexate—colon cancer	0.000299	0.000797	CcSEcCtD
Ziprasidone—Mental disorder—Methotrexate—colon cancer	0.000297	0.00079	CcSEcCtD
Ziprasidone—Erythema—Methotrexate—colon cancer	0.000295	0.000785	CcSEcCtD
Ziprasidone—Malnutrition—Methotrexate—colon cancer	0.000295	0.000785	CcSEcCtD
Ziprasidone—Nausea—Vincristine—colon cancer	0.000295	0.000784	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000295	0.000784	CcSEcCtD
Ziprasidone—Vomiting—Fluorouracil—colon cancer	0.000294	0.000783	CcSEcCtD
Ziprasidone—Insomnia—Capecitabine—colon cancer	0.000293	0.000778	CcSEcCtD
Ziprasidone—Rash—Fluorouracil—colon cancer	0.000292	0.000776	CcSEcCtD
Ziprasidone—Dermatitis—Fluorouracil—colon cancer	0.000292	0.000776	CcSEcCtD
Ziprasidone—Paraesthesia—Capecitabine—colon cancer	0.00029	0.000773	CcSEcCtD
Ziprasidone—Headache—Fluorouracil—colon cancer	0.00029	0.000771	CcSEcCtD
Ziprasidone—Dyspnoea—Capecitabine—colon cancer	0.000288	0.000767	CcSEcCtD
Ziprasidone—Nausea—Irinotecan—colon cancer	0.000287	0.000764	CcSEcCtD
Ziprasidone—Back pain—Methotrexate—colon cancer	0.000285	0.000759	CcSEcCtD
Ziprasidone—Dyspepsia—Capecitabine—colon cancer	0.000285	0.000757	CcSEcCtD
Ziprasidone—Decreased appetite—Capecitabine—colon cancer	0.000281	0.000748	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000279	0.000743	CcSEcCtD
Ziprasidone—Fatigue—Capecitabine—colon cancer	0.000279	0.000742	CcSEcCtD
Ziprasidone—Vision blurred—Methotrexate—colon cancer	0.000278	0.00074	CcSEcCtD
Ziprasidone—Constipation—Capecitabine—colon cancer	0.000277	0.000736	CcSEcCtD
Ziprasidone—Nausea—Fluorouracil—colon cancer	0.000275	0.000731	CcSEcCtD
Ziprasidone—Anaemia—Methotrexate—colon cancer	0.000273	0.000725	CcSEcCtD
Ziprasidone—Feeling abnormal—Capecitabine—colon cancer	0.000267	0.000709	CcSEcCtD
Ziprasidone—Vertigo—Methotrexate—colon cancer	0.000265	0.000705	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Capecitabine—colon cancer	0.000264	0.000704	CcSEcCtD
Ziprasidone—Leukopenia—Methotrexate—colon cancer	0.000264	0.000703	CcSEcCtD
Ziprasidone—Clozapine—ABCB1—colon cancer	0.00026	0.212	CrCbGaD
Ziprasidone—Cough—Methotrexate—colon cancer	0.000257	0.000685	CcSEcCtD
Ziprasidone—Urticaria—Capecitabine—colon cancer	0.000257	0.000684	CcSEcCtD
Ziprasidone—Abdominal pain—Capecitabine—colon cancer	0.000256	0.00068	CcSEcCtD
Ziprasidone—Body temperature increased—Capecitabine—colon cancer	0.000256	0.00068	CcSEcCtD
Ziprasidone—Myalgia—Methotrexate—colon cancer	0.000251	0.000668	CcSEcCtD
Ziprasidone—Chest pain—Methotrexate—colon cancer	0.000251	0.000668	CcSEcCtD
Ziprasidone—Arthralgia—Methotrexate—colon cancer	0.000251	0.000668	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000249	0.000664	CcSEcCtD
Ziprasidone—Confusional state—Methotrexate—colon cancer	0.000243	0.000646	CcSEcCtD
Ziprasidone—Infection—Methotrexate—colon cancer	0.000239	0.000636	CcSEcCtD
Ziprasidone—Hypersensitivity—Capecitabine—colon cancer	0.000238	0.000634	CcSEcCtD
Ziprasidone—Nervous system disorder—Methotrexate—colon cancer	0.000236	0.000628	CcSEcCtD
Ziprasidone—Thrombocytopenia—Methotrexate—colon cancer	0.000236	0.000627	CcSEcCtD
Ziprasidone—Skin disorder—Methotrexate—colon cancer	0.000234	0.000622	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methotrexate—colon cancer	0.000233	0.000619	CcSEcCtD
Ziprasidone—Asthenia—Capecitabine—colon cancer	0.000232	0.000617	CcSEcCtD
Ziprasidone—Anorexia—Methotrexate—colon cancer	0.000229	0.000611	CcSEcCtD
Ziprasidone—Hypotension—Methotrexate—colon cancer	0.000225	0.000599	CcSEcCtD
Ziprasidone—Diarrhoea—Capecitabine—colon cancer	0.000221	0.000589	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000219	0.000584	CcSEcCtD
Ziprasidone—Insomnia—Methotrexate—colon cancer	0.000218	0.000579	CcSEcCtD
Ziprasidone—Paraesthesia—Methotrexate—colon cancer	0.000216	0.000575	CcSEcCtD
Ziprasidone—Dyspnoea—Methotrexate—colon cancer	0.000215	0.000571	CcSEcCtD
Ziprasidone—Somnolence—Methotrexate—colon cancer	0.000214	0.000569	CcSEcCtD
Ziprasidone—Dizziness—Capecitabine—colon cancer	0.000214	0.000569	CcSEcCtD
Ziprasidone—Dyspepsia—Methotrexate—colon cancer	0.000212	0.000564	CcSEcCtD
Ziprasidone—Decreased appetite—Methotrexate—colon cancer	0.000209	0.000557	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000208	0.000553	CcSEcCtD
Ziprasidone—Fatigue—Methotrexate—colon cancer	0.000208	0.000552	CcSEcCtD
Ziprasidone—Vomiting—Capecitabine—colon cancer	0.000206	0.000547	CcSEcCtD
Ziprasidone—Rash—Capecitabine—colon cancer	0.000204	0.000543	CcSEcCtD
Ziprasidone—Dermatitis—Capecitabine—colon cancer	0.000204	0.000542	CcSEcCtD
Ziprasidone—Headache—Capecitabine—colon cancer	0.000203	0.000539	CcSEcCtD
Ziprasidone—Feeling abnormal—Methotrexate—colon cancer	0.000198	0.000528	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methotrexate—colon cancer	0.000197	0.000524	CcSEcCtD
Ziprasidone—Nausea—Capecitabine—colon cancer	0.000192	0.000511	CcSEcCtD
Ziprasidone—Urticaria—Methotrexate—colon cancer	0.000191	0.000509	CcSEcCtD
Ziprasidone—Abdominal pain—Methotrexate—colon cancer	0.00019	0.000506	CcSEcCtD
Ziprasidone—Body temperature increased—Methotrexate—colon cancer	0.00019	0.000506	CcSEcCtD
Ziprasidone—Hypersensitivity—Methotrexate—colon cancer	0.000177	0.000472	CcSEcCtD
Ziprasidone—Asthenia—Methotrexate—colon cancer	0.000173	0.00046	CcSEcCtD
Ziprasidone—Diarrhoea—Methotrexate—colon cancer	0.000165	0.000438	CcSEcCtD
Ziprasidone—Dizziness—Methotrexate—colon cancer	0.000159	0.000424	CcSEcCtD
Ziprasidone—Vomiting—Methotrexate—colon cancer	0.000153	0.000407	CcSEcCtD
Ziprasidone—Rash—Methotrexate—colon cancer	0.000152	0.000404	CcSEcCtD
Ziprasidone—Dermatitis—Methotrexate—colon cancer	0.000152	0.000404	CcSEcCtD
Ziprasidone—Headache—Methotrexate—colon cancer	0.000151	0.000401	CcSEcCtD
Ziprasidone—Nausea—Methotrexate—colon cancer	0.000143	0.00038	CcSEcCtD
Ziprasidone—HTR1D—Signaling Pathways—TP53—colon cancer	2.45e-06	0.000157	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CASP3—colon cancer	2.45e-06	0.000157	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CASP3—colon cancer	2.44e-06	0.000156	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—PIK3CA—colon cancer	2.44e-06	0.000156	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—AKT1—colon cancer	2.44e-06	0.000156	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCND1—colon cancer	2.43e-06	0.000156	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—AKT1—colon cancer	2.43e-06	0.000156	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—EP300—colon cancer	2.43e-06	0.000156	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VEGFA—colon cancer	2.42e-06	0.000155	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CASP3—colon cancer	2.42e-06	0.000155	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CTNNB1—colon cancer	2.41e-06	0.000154	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CASP3—colon cancer	2.41e-06	0.000154	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—PIK3CA—colon cancer	2.41e-06	0.000154	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VEGFA—colon cancer	2.4e-06	0.000154	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—SRC—colon cancer	2.4e-06	0.000154	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—EP300—colon cancer	2.4e-06	0.000154	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—colon cancer	2.4e-06	0.000153	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCND1—colon cancer	2.39e-06	0.000153	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCND1—colon cancer	2.39e-06	0.000153	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—KRAS—colon cancer	2.39e-06	0.000153	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARG—colon cancer	2.39e-06	0.000153	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NRAS—colon cancer	2.39e-06	0.000153	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCND1—colon cancer	2.38e-06	0.000152	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NRAS—colon cancer	2.37e-06	0.000152	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCND1—colon cancer	2.37e-06	0.000152	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CTNNB1—colon cancer	2.37e-06	0.000152	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CTNNB1—colon cancer	2.37e-06	0.000151	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—SRC—colon cancer	2.36e-06	0.000151	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—HRAS—colon cancer	2.36e-06	0.000151	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CTNNB1—colon cancer	2.36e-06	0.000151	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—colon cancer	2.36e-06	0.000151	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—KRAS—colon cancer	2.36e-06	0.000151	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—HRAS—colon cancer	2.36e-06	0.000151	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CDKN1A—colon cancer	2.35e-06	0.000151	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCND1—colon cancer	2.35e-06	0.000151	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CTNNB1—colon cancer	2.35e-06	0.000151	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCND1—colon cancer	2.34e-06	0.00015	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—HRAS—colon cancer	2.34e-06	0.00015	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VEGFA—colon cancer	2.34e-06	0.00015	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CTNNB1—colon cancer	2.33e-06	0.000149	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—colon cancer	2.33e-06	0.000149	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—HRAS—colon cancer	2.32e-06	0.000149	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CTNNB1—colon cancer	2.32e-06	0.000149	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CDKN1A—colon cancer	2.32e-06	0.000148	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CDKN1A—colon cancer	2.31e-06	0.000148	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NRAS—colon cancer	2.31e-06	0.000148	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CDKN1A—colon cancer	2.3e-06	0.000147	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—PIK3CA—colon cancer	2.3e-06	0.000147	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MYC—colon cancer	2.3e-06	0.000147	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VEGFA—colon cancer	2.3e-06	0.000147	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—colon cancer	2.3e-06	0.000147	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CDKN1A—colon cancer	2.3e-06	0.000147	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—HRAS—colon cancer	2.29e-06	0.000147	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—AKT1—colon cancer	2.29e-06	0.000147	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CDKN1A—colon cancer	2.27e-06	0.000146	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NRAS—colon cancer	2.27e-06	0.000146	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CDKN1A—colon cancer	2.27e-06	0.000145	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—AKT1—colon cancer	2.26e-06	0.000145	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—HRAS—colon cancer	2.26e-06	0.000144	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—AKT1—colon cancer	2.26e-06	0.000144	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—EGFR—colon cancer	2.25e-06	0.000144	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—AKT1—colon cancer	2.25e-06	0.000144	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—PIK3CA—colon cancer	2.25e-06	0.000144	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ABCB1—colon cancer	2.24e-06	0.000144	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—AKT1—colon cancer	2.24e-06	0.000144	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EP300—colon cancer	2.24e-06	0.000143	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CASP3—colon cancer	2.24e-06	0.000143	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—AKT1—colon cancer	2.24e-06	0.000143	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—colon cancer	2.23e-06	0.000143	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—HRAS—colon cancer	2.23e-06	0.000142	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MYC—colon cancer	2.22e-06	0.000142	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—colon cancer	2.22e-06	0.000142	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—AKT1—colon cancer	2.21e-06	0.000142	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MYC—colon cancer	2.21e-06	0.000142	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—AKT1—colon cancer	2.21e-06	0.000141	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—colon cancer	2.21e-06	0.000141	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—TYMS—colon cancer	2.2e-06	0.000141	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EP300—colon cancer	2.2e-06	0.000141	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EP300—colon cancer	2.2e-06	0.000141	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.2e-06	0.000141	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—EP300—colon cancer	2.2e-06	0.000141	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—PIK3CA—colon cancer	2.2e-06	0.000141	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EP300—colon cancer	2.19e-06	0.00014	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EP300—colon cancer	2.19e-06	0.00014	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—PIK3CA—colon cancer	2.18e-06	0.00014	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCND1—colon cancer	2.18e-06	0.000139	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—SRC—colon cancer	2.18e-06	0.000139	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—EGFR—colon cancer	2.17e-06	0.000139	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—PIK3CA—colon cancer	2.17e-06	0.000139	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EP300—colon cancer	2.16e-06	0.000139	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—EGFR—colon cancer	2.16e-06	0.000138	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EP300—colon cancer	2.16e-06	0.000138	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CTNNB1—colon cancer	2.16e-06	0.000138	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MYC—colon cancer	2.15e-06	0.000138	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—colon cancer	2.15e-06	0.000137	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—SRC—colon cancer	2.14e-06	0.000137	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—SRC—colon cancer	2.14e-06	0.000137	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—SRC—colon cancer	2.13e-06	0.000136	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—HRAS—colon cancer	2.13e-06	0.000136	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—KRAS—colon cancer	2.13e-06	0.000136	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—SRC—colon cancer	2.13e-06	0.000136	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—colon cancer	2.12e-06	0.000136	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VEGFA—colon cancer	2.12e-06	0.000136	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MYC—colon cancer	2.12e-06	0.000136	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—colon cancer	2.11e-06	0.000135	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CDKN1A—colon cancer	2.11e-06	0.000135	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—SRC—colon cancer	2.1e-06	0.000135	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—EGFR—colon cancer	2.1e-06	0.000135	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—SRC—colon cancer	2.1e-06	0.000134	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NRAS—colon cancer	2.1e-06	0.000134	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—colon cancer	2.1e-06	0.000134	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VEGFA—colon cancer	2.09e-06	0.000134	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VEGFA—colon cancer	2.08e-06	0.000133	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—AKT1—colon cancer	2.08e-06	0.000133	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—AKT1—colon cancer	2.08e-06	0.000133	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VEGFA—colon cancer	2.08e-06	0.000133	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—EGFR—colon cancer	2.07e-06	0.000133	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VEGFA—colon cancer	2.07e-06	0.000132	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—AKT1—colon cancer	2.07e-06	0.000132	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NRAS—colon cancer	2.06e-06	0.000132	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NRAS—colon cancer	2.06e-06	0.000132	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—KRAS—colon cancer	2.05e-06	0.000132	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—AKT1—colon cancer	2.05e-06	0.000131	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NRAS—colon cancer	2.05e-06	0.000131	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VEGFA—colon cancer	2.05e-06	0.000131	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NRAS—colon cancer	2.04e-06	0.000131	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VEGFA—colon cancer	2.04e-06	0.000131	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—KRAS—colon cancer	2.04e-06	0.000131	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—HRAS—colon cancer	2.03e-06	0.00013	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NRAS—colon cancer	2.02e-06	0.00013	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—AKT1—colon cancer	2.02e-06	0.00013	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARG—colon cancer	2.02e-06	0.00013	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NRAS—colon cancer	2.02e-06	0.000129	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EP300—colon cancer	2.01e-06	0.000128	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—HRAS—colon cancer	2e-06	0.000128	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—AKT1—colon cancer	1.99e-06	0.000127	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—KRAS—colon cancer	1.99e-06	0.000127	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—AKT1—colon cancer	1.97e-06	0.000126	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—KRAS—colon cancer	1.96e-06	0.000125	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—PIK3CA—colon cancer	1.96e-06	0.000125	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MYC—colon cancer	1.95e-06	0.000125	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—SRC—colon cancer	1.95e-06	0.000125	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—colon cancer	1.95e-06	0.000125	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PIK3CA—colon cancer	1.93e-06	0.000124	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MYC—colon cancer	1.92e-06	0.000123	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MYC—colon cancer	1.92e-06	0.000123	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—colon cancer	1.92e-06	0.000123	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—colon cancer	1.91e-06	0.000122	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MYC—colon cancer	1.91e-06	0.000122	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EGFR—colon cancer	1.91e-06	0.000122	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—colon cancer	1.91e-06	0.000122	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MYC—colon cancer	1.9e-06	0.000122	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—colon cancer	1.9e-06	0.000122	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VEGFA—colon cancer	1.9e-06	0.000122	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—colon cancer	1.89e-06	0.000121	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—PIK3CA—colon cancer	1.89e-06	0.000121	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MYC—colon cancer	1.89e-06	0.000121	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—AKT1—colon cancer	1.88e-06	0.00012	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—colon cancer	1.88e-06	0.00012	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MYC—colon cancer	1.88e-06	0.00012	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—colon cancer	1.88e-06	0.00012	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EGFR—colon cancer	1.88e-06	0.00012	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—PIK3CA—colon cancer	1.88e-06	0.00012	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—colon cancer	1.88e-06	0.00012	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NRAS—colon cancer	1.88e-06	0.00012	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EGFR—colon cancer	1.87e-06	0.00012	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EGFR—colon cancer	1.87e-06	0.00012	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EGFR—colon cancer	1.86e-06	0.000119	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EGFR—colon cancer	1.84e-06	0.000118	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EGFR—colon cancer	1.84e-06	0.000118	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—AKT1—colon cancer	1.84e-06	0.000118	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—PIK3CA—colon cancer	1.83e-06	0.000117	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—colon cancer	1.83e-06	0.000117	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—colon cancer	1.82e-06	0.000116	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—HRAS—colon cancer	1.81e-06	0.000116	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—KRAS—colon cancer	1.8e-06	0.000115	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—PIK3CA—colon cancer	1.8e-06	0.000115	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—AKT1—colon cancer	1.79e-06	0.000115	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—AKT1—colon cancer	1.78e-06	0.000114	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—KRAS—colon cancer	1.77e-06	0.000114	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PIK3CA—colon cancer	1.77e-06	0.000114	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—KRAS—colon cancer	1.77e-06	0.000113	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—AKT1—colon cancer	1.77e-06	0.000113	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—colon cancer	1.77e-06	0.000113	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—KRAS—colon cancer	1.77e-06	0.000113	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—KRAS—colon cancer	1.76e-06	0.000113	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MYC—colon cancer	1.75e-06	0.000112	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—HRAS—colon cancer	1.75e-06	0.000112	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—colon cancer	1.74e-06	0.000112	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—KRAS—colon cancer	1.74e-06	0.000112	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—colon cancer	1.74e-06	0.000111	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—KRAS—colon cancer	1.74e-06	0.000111	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—HRAS—colon cancer	1.74e-06	0.000111	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EGFR—colon cancer	1.71e-06	0.000109	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—HRAS—colon cancer	1.69e-06	0.000108	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—HRAS—colon cancer	1.66e-06	0.000106	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—PIK3CA—colon cancer	1.66e-06	0.000106	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—PIK3CA—colon cancer	1.63e-06	0.000104	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—PIK3CA—colon cancer	1.63e-06	0.000104	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PIK3CA—colon cancer	1.63e-06	0.000104	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—PIK3CA—colon cancer	1.62e-06	0.000104	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—PIK3CA—colon cancer	1.62e-06	0.000103	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—KRAS—colon cancer	1.61e-06	0.000103	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—colon cancer	1.6e-06	0.000103	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—PIK3CA—colon cancer	1.6e-06	0.000102	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AKT1—colon cancer	1.6e-06	0.000102	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—PIK3CA—colon cancer	1.6e-06	0.000102	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—colon cancer	1.59e-06	0.000102	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—AKT1—colon cancer	1.58e-06	0.000101	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—colon cancer	1.58e-06	0.000101	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—colon cancer	1.57e-06	0.000101	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—colon cancer	1.57e-06	0.0001	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—colon cancer	1.56e-06	0.0001	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—EP300—colon cancer	1.56e-06	0.0001	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARG—colon cancer	1.56e-06	0.0001	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—colon cancer	1.55e-06	9.91e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—colon cancer	1.54e-06	9.89e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AKT1—colon cancer	1.54e-06	9.87e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AKT1—colon cancer	1.53e-06	9.82e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—HRAS—colon cancer	1.53e-06	9.81e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—HRAS—colon cancer	1.51e-06	9.66e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—HRAS—colon cancer	1.51e-06	9.64e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—HRAS—colon cancer	1.5e-06	9.61e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—HRAS—colon cancer	1.5e-06	9.57e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AKT1—colon cancer	1.49e-06	9.55e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PIK3CA—colon cancer	1.48e-06	9.5e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—HRAS—colon cancer	1.48e-06	9.48e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—HRAS—colon cancer	1.48e-06	9.46e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AKT1—colon cancer	1.47e-06	9.4e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—AKT1—colon cancer	1.45e-06	9.28e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—colon cancer	1.44e-06	9.19e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—HRAS—colon cancer	1.37e-06	8.79e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AKT1—colon cancer	1.35e-06	8.67e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AKT1—colon cancer	1.33e-06	8.53e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AKT1—colon cancer	1.33e-06	8.51e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—AKT1—colon cancer	1.33e-06	8.5e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AKT1—colon cancer	1.33e-06	8.48e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—EP300—colon cancer	1.32e-06	8.47e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AKT1—colon cancer	1.32e-06	8.45e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AKT1—colon cancer	1.31e-06	8.37e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AKT1—colon cancer	1.3e-06	8.35e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—colon cancer	1.23e-06	7.86e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AKT1—colon cancer	1.21e-06	7.76e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PIK3CA—colon cancer	1.16e-06	7.4e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—EP300—colon cancer	1.02e-06	6.54e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PIK3CA—colon cancer	9.79e-07	6.27e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AKT1—colon cancer	9.44e-07	6.05e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AKT1—colon cancer	8e-07	5.12e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PIK3CA—colon cancer	7.56e-07	4.84e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AKT1—colon cancer	6.17e-07	3.95e-05	CbGpPWpGaD
